SCHEMBL8894866

SCHEMBL8894866

CC(=O)NC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8894589 0.80
SCHEMBL11123806 0.80 EPHX1 (0.40)
SCHEMBL6363154 0.76
SCHEMBL124179 0.76
SCHEMBL14446732 0.75 EPHX1 (0.37)
SCHEMBL2825781 0.73
SCHEMBL9913287 0.73 EPHX1 (0.40)
Lithium SCHEMBL669188 0.73
SCHEMBL15670607 0.73
Hydrochloric Acid SCHEMBL30777463 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5612382-A Composition for percutaneous absorption of pharmaceutically active ingredients Fike, Frances B. (US) 1997-03-18 US claimed
US-8951999-B2 Compounds OREXO AB (SE) 2015-02-10 US disclosed
US-20110263556-A1 New Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-27 US disclosed
US-5612382-A Composition for percutaneous absorption of pharmaceutically active ingredients Fike, Frances B. (US) 1997-03-18 US disclosed